Page last updated: 2024-12-08

potassium permanganate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Potassium Permanganate: Permanganic acid (HMnO4), potassium salt. A highly oxidative, water-soluble compound with purple crystals, and a sweet taste. (From McGraw-Hill Dictionary of Scientific and Technical Information, 4th ed) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID516875
MeSH IDM0017385

Synonyms (101)

Synonym
AKOS015833392
ci 77755
solo san soo
diversey diversol cx with arodyne
permanganato potasico [spanish]
walko tablets
epa pesticide chemical code 068501
ccris 5561
potassium permanganate [jan]
diversey diversol cxu
caswell no. 699
potassium permanganate (kmno4)
hilco #88
nsc 146182
ai3-52835
algae-k
icc 237 disinfectant, sanitizer, destainer, and deodorizer
kaliumpermanganat [german]
hsdb 1218
pure light e 2
potassium (permanganate de) [french]
potassio (permanganato di) [italian]
permanganate de potassium [french]
un1490
einecs 231-760-3
argucide
potassium permanganate
insta-perm
permanganate de potassium
manganese potassium oxide (kmno4)
potassio (permanganato di)
7722-64-7
kaliumpermanganat
chameleon mineral
cairox
condy's crystals
c.i. 77755
potassium (permanganate de)
permanganic acid (hmno4), potassium salt
permanganate of potash
nsc-146182
D02053
potassium permanganate (tn)
potassium permanganate (jp17/usp)
permanganate, potassium
permanganic acid (hmno4), potassium salt (1:1)
unii-00ot1qx5u4
permanganato potasico
potassium permanganate [usp:jan]
ec 231-760-3
00ot1qx5u4 ,
potassium permanganate [un1490] [oxidizer]
P1742
FT-0645093
kali permanganicum
potassium permanganate [who-dd]
potassium permanganate [ep monograph]
potassium permanganate [usp monograph]
kali permanganicum [hpus]
potassium permanganate [hsdb]
potassium permanganate [mart.]
potassium permanganate [mi]
potassium permanganate [vandf]
VZJVWSHVAAUDKD-UHFFFAOYSA-N
kmno4
potassiumpermanganate
potasiumpermanganate
DTXSID2034839 ,
mfcd00011364
potassium permanganate, low in mercury (max. 0,005 ppm hg)
potassium permanganate, acs reagent, >=99.0%, low in mercury
potassium permanganate, acs reagent, >=99.0%
potassium permanganate, puriss., meets analytical specification of ph. eur., bp, usp, 99-100.5%
potassium permanganate, suitable for determination of nitroxide, >=99.3%
potassium permanganate, purum p.a., >=99.0% (rt), fine crystals
potassium permanganate, 97% ,
potassium permanganate, suitable for determination of toxic metals, >=99.5%
potassium permanganate, saj first grade, >=99.3%
potassium permanganate, bioultra, >=99.0% (rt)
potassium permanganate, puriss. p.a., acs reagent, hg <=0.000005%, >=99.0% (rt)
potassium permanganate, jis special grade, >=99.3%
potassium permanganate, <=150 mum particle size, 97%
potassium permanganate, puriss. p.a., acs reagent, reag. ph. eur., >=99%
potassium permanganate, tested according to ph.eur.
potassium permanganate, lr, >=99%
potassium permanganate, p.a., acs reagent, reag. iso, 99.0%
potassium permanganate, p.a., 99.0%
potassium permanganate, meets usp testing specifications
potassium permanganate, acs reagent
potassium permanganate, p.a., acs reagent, reag. iso, reag. ph. eur., 99.0-100.5%
DB13831
Q190865
potassium;permanganate
dtxcid0014839
chlorisol
potassium permanganate (mart.)
potassium permanganate (ep monograph)
potassium permanganate (usp:jan)
potassium permanganate (usp monograph)
caswell number 699
potassium permanganate solution, 1.25n

Research Excerpts

Overview

Potassium permanganate (KMnO(4) is a commonly employed oxidant that has been shown to rapidly destroy DNAPL compounds like PCE and TCE following second-order kinetics in an aqueous system. It is a mild antiseptic with astringent properties.

ExcerptReferenceRelevance
"Potassium permanganate (KMnO(4)) is a commonly employed oxidant that has been shown to rapidly destroy DNAPL compounds like PCE and TCE following second-order kinetics in an aqueous system."( Intermediate-scale 2D experimental investigation of in situ chemical oxidation using potassium permanganate for remediation of complex DNAPL source zones.
Heiderscheidt, JL; Illangasekare, TH; Siegrist, RL, 2008
)
1.29
"Potassium permanganate is a mild antiseptic with astringent properties. "( Should potassium permanganate be used in wound care?
Anderson, I,
)
2.03
"Potassium permanganate is an example."( Potassium permanganate poisoning--a rare cause of fatal self poisoning.
Cheung, WL; Ong, KL; Tan, TH, 1997
)
2.46
"Potassium permanganate is an oxidant heavily used in fish culture. "( Effects of the oxidant potassium permanganate on the expression of gill metallothionein mRNA and its relationship to sublethal whole animal endpoints in channel catfish.
Colley, WC; El-Alfy, A; Griffin, BR; Kirby, R; Schlenk, D, 2000
)
2.06

Effects

Potassium permanganate (KMnO4) has widely been used in genomic footprinting assays to map unusual gene structures. Oral potassiumpermanganate is used in the management of terminal carcinoma in three patients.

ExcerptReferenceRelevance
"Potassium permanganate solution has been used both as a fixative and as a staining for ultrathin sections at transmission electron microscopy, due to its ability to provide good contrast of different tissue components. "( Rediscover Potassium Permanganate as a Stain for Basic Proteins on Ultrathin Sections at Transmission Electron Microscopy.
Biggiogera, M; Casali, C; Zannino, L, 2023
)
2.74
"Potassium permanganate (KMnO4) has widely been used in genomic footprinting assays to map unusual gene structures, including the melting DNA block in transcriptional elongation that results from promoter-proximal pausing of RNA polymerase (Pol) II complexes. "( Potassium permanganate as a probe to map DNA-protein interactions in vivo.
Chasson, L; Ferrier, P; Kumar, S; Payet-Bornet, D; Spicuglia, S, 2004
)
3.21
"Oral potassium permanganate has been used in the management of terminal carcinoma in three patients. "( The management of terminal carcinoma with oral potassium permanganate.
Sokhi, G, 1970
)
1.02

Treatment

ExcerptReferenceRelevance
"Potassium permanganate treatment of amyloid abolishes congo red stain affinity for amyloid of unknown origin found in secondary amyloidosis."( Amyloid in a patient with Reiter's syndrome - secondary or coincidental? Differentiation with potassium permanganate.
Mahowald, ML; Pritzker, M; Sarosi, GA; Sumner, HW; Valls, AA,
)
1.07

Toxicity

ExcerptReferenceRelevance
"Whilst chemical cleavage of mismatch (CCM) detects all point mutations in DNA, its widespread use has been hampered by the complex multistage methodology and the need for toxic chemicals, in particular osmium tetroxide."( Potassium permanganate and tetraethylammonium chloride are a safe and effective substitute for osmium tetroxide in solid-phase fluorescent chemical cleavage of mismatch.
Deeble, VJ; Roberts, E; Taylor, GR; Woods, CG, 1997
)
1.74
" Previous studies have demonstrated that chlorine and potassium permanganate are feasible oxidants for the removal of MCs present in drinking water resources, although the oxidation might lead to toxic oxidation products."( Oxidation of MC-LR and -RR with chlorine and potassium permanganate: toxicity of the reaction products.
Acero, JL; Meriluoto, J; Rodríguez, EM; Spoof, L, 2008
)
0.85
"Three toxic substances have been made into a mixture administered intravenously, similar to methcathinone."( Neurotoxicity following chronic intravenous use of "Russian cocktail".
Delipoyraz, I; Filiz, G; Gecim, NO; Tireli, H; Varlibas, F; Yuksel, G, 2009
)
0.35
"0, 500, 1000, 1500, 2000, 2500, 3000 and 3500mg/kg body weight to groups 1, 2, 3, 4, 5, 6, 7 and 8, ten per group for LD50 determination."( Acute toxicity studies of potassium permanganate in Swiss albino mice.
Ahur, VM; Saganuwan, SA; Yohanna, CA,
)
0.43
" No toxic effects of C-PE were observed to any of the cell lines tested."( Purified c-phycoerythrin: safety studies in rats and protective role against permanganate-mediated fibroblast-DNA damage.
Dalwadi, N; Khalil, C; Madamwar, D; Soni, B; Visavadiya, NP; Winder, C, 2010
)
0.36
"For characterizing the three-factorial toxicity, we proposed a new health risk-oriented approach, the gist of which is a classification of effects depending on whether a binary combined toxicity's type remains virtually the same or appears to be either more or less adverse when modeled against the background of a third toxic."( Further development of the theory and mathematical description of combined toxicity: An approach to classifying types of action of three-factorial combinations (a case study of manganese-chromium-nickel subchronic intoxication).
Grebenkina, SV; Katsnelson, BA; Minigaliyeva, IA; Panov, VG; Privalova, LI; Slyshkina, TV; Varaksin, AN, 2015
)
0.42

Compound-Compound Interactions

ExcerptReferenceRelevance
" A flotation process was designed for flotation separation of PVC and PET plastics combined with surface modification."( Flotation separation of polyvinyl chloride and polyethylene terephthalate plastics combined with surface modification for recycling.
Fu, J; Liu, Y; Luo, C; Wang, C; Wang, H; Zhang, L, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" The increasing gas flow rate has a positive effect on the absorption rate of SO2."( Simultaneous absorption of SO2 and NO from flue gas with KMnO4/NaOH solutions.
Chien, TW; Chu, H; Li, SY, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" A sample with no organic solvent induced DNA damage in human lymphocytes with a dose-response relationship as determined by SCGA."( Genotoxic activity of potassium permanganate in acidic solutions.
Castegnaro, M; De Méo, M; Duménil, G; Laget, M, 1991
)
0.6
"To our knowledge, this is the first case report of a multiple, low dosage ingestion of manganese."( Chronic enteral poisoning caused by potassium permanganate: a case report.
Beuche, W; Holzgraefe, M; Kijewski, H; Poser, W, 1986
)
0.55
" The proposed methods have been applied successfully for the analysis of the drug in pure form and in its dosage forms."( Spectrophotometric determination of loperamide hydrochloride by acid-dye and charge-transfer complexation methods in the presence of its degradation products.
El Sherif, ZA; Mohamed, AO; Tarras, FM; Walash, MI, 2000
)
0.31
" The method was applied successfully in determining the drugs in dosage forms and in biological fluids."( Determination of phenolic sympathomimetic drugs in pharmaceutical samples and biological fluids by flow-injection chemiluminescence.
Al-Tamimi, SA; Alwarthan, AA; Aly, FA,
)
0.13
" The proposed method was applied successfully to the determination of benazepril in its dosage forms, the percentage recoveries +/- SD (n = 9) were 99."( Spectrophotometric determination of benazepril in tablets.
Abounassif, MA; Al-Zaagi, IA; Belal, F,
)
0.13
" The proposed methods were successfully applied for the determination of dothiepin hydrochloride in bulk powder and in capsule dosage form."( Kinetic spectrophotometric methods for the determination of dothiepin hydrochloride in bulk and in drug formulation.
Taha, EA, 2003
)
0.32
" The method was successfully applied to the determination of enalapril maleate in dosage forms and biological fluids without interferences."( Flow-injection chemiluminescence determination of enalapril maleate in pharmaceuticals and biological fluids using tris(2,2'-bipyridyl)ruthenium(II).
Alarfaj, NA, 2003
)
0.32
" With Fe(III) dosage increasing from 2mg/L to 8mg/L, As removal increased from 41."( [Effectiveness and mechanism of permanganate enhancing arsenite co-precipitation with ferric chloride].
Li, GB; Li, X; Liu, RP; Wu, RC; Xia, SJ, 2005
)
0.33
"5, 3, and 5 times the concentration used for the therapeutic dosage; and at the concentration used for the therapeutic dosage but for 3 or 5 times the recommended exposure time."( Tolerance of benzalkonium chloride, formalin, malachite green, and potassium permanganate in goldfish and zebrafish.
Di Bello, D; Intorre, L; Meucci, V; Monni, G; Pretti, C; Soldani, G, 2007
)
0.58
"In both species, exposure to malachite green at the therapeutic dosage resulted in toxic effects, including death."( Tolerance of benzalkonium chloride, formalin, malachite green, and potassium permanganate in goldfish and zebrafish.
Di Bello, D; Intorre, L; Meucci, V; Monni, G; Pretti, C; Soldani, G, 2007
)
0.58
"The oxidation of As(III) with potassium permanganate was studied under conditions including pH, initial As(III) concentration and dosage of Mn(VII)."( Oxidation of As(III) by potassium permanganate.
Fan, M; Huang, CP; Li, N; Saha, B; Van Leeuwen, J; Yang, H, 2007
)
0.94
" An optimum permanganate dosage for algal coagulation was identified for pilot and laboratory tests."( Potassium permanganate as an alternative preoxidant for enhancing algal coagulation--pilot and bench scale studies.
Chen, JJ; Tseng, IC; Yeh, HH, 2008
)
1.79
" The optimum As(III) removal was achieved at a permanganate dosage of 18."( Removal of arsenic from water: effect of calcium ions on As(III) removal in the KMnO(4)-Fe(II) process.
Dong, H; Guan, X; Jiang, L; Ma, J, 2009
)
0.35
"The DSC technique applied to the study of the toxic impact of permanganate on bacterial cell culture detected the lack of linearity in the dose-response effect."( Thermal analysis of whole bacterial cells exposed to potassium permanganate using differential scanning calorimetry: a biphasic dose-dependent response to stress.
Abuladze, MK; Bakradze, NB; Gogichaishvili, Sh; Kiziria, E; Lejava, LV; Namchevadze, EN; Sokhadze, VM; Tabatadze, LV, 2009
)
0.6
" Adsorption experiments were then conducted with KMnO(4)-modified activated carbon to study the effects of carbon dosage (250-1500 mg/L), pH (2-10), ion strength (0-0."( Adsorption of Basic Violet 14 in aqueous solutions using KMnO4-modified activated carbon.
Nie, W; Shi, Q; Zhang, B; Zhang, C; Zhang, H; Zhang, J, 2010
)
0.36
" The removal percentage of trace MIB at any given time for a particular carbon dosage was irrelative to the initial concentration of MIB."( Comparative study on the removal technologies of 2-methylisoborneol (MIB) in drinking water.
Ge, XP; Liang, CZ; Sun, W; Wang, DS; Yang, M, 2006
)
0.33
" aeruginosa by KMnO(4), achieved by dosing Fe(II) after a period of pre-oxidation, to cease the further release of intracellular organic matter (IOM) and the degradation of dissolved organic matter (DOM)."( Effect of moderate pre-oxidation on the removal of Microcystis aeruginosa by KMnO4-Fe(II) process: significance of the in-situ formed Fe(III).
Liu, H; Liu, R; Ma, M; Qu, J, 2012
)
0.38
" In FBR experiments of synthesizing MnBT-4, the Fe and Mn salts were found to have an optimal dosage ratio of less than 4, which maximized the KMnO(4) immobilization efficiency."( Novel KMnO4-modified iron oxide for effective arsenite removal.
Cheng, FJ; Huang, YH; Shih, YJ, 2011
)
0.37
" While KMnO(4) is too soluble to be used in reactive barriers, MCP could be introduced into the aquifer by filling of trenches or boreholes; this would allow a prolonged passive dosing of permanganate into the flowing groundwater."( Stabilization of potassium permanganate particles with manganese dioxide.
Georgi, A; Kopinke, FD; Rusevova, K, 2012
)
0.72
" The proposed method was used for estimation of the drug in a novel controlled release dosage form."( Utility of an oxidation reaction for the spectrophotometric determination of acarbose in controlled release tablets at various simulated gastrointestinal media.
Kumar, RV; Sinha, VR,
)
0.13
" The proposed method was successfully applied for the simultaneous determination of both drugs in pharmaceutical dosage forms and human urine samples and compared with alternative HPLC method."( Kinetic spectrophotometric H-point standard addition method for the simultaneous determination of diloxanide furoate and metronidazole in binary mixtures and biological fluids.
Abu Shanab, AM; Issa, MM; Nejem, RM; Shaat, NT, 2013
)
0.39
" KMnO4 pre-oxidation improved the coagulation efficiency of algal at a low dosage of PAC."( Pre-oxidation with KMnO4 changes extra-cellular organic matter's secretion characteristics to improve algal removal by coagulation with a low dosage of polyaluminium chloride.
Gao, N; Hu, Y; Qiao, J; Wang, L; Zhang, L; Zhou, Q, 2013
)
0.39
" The initial rate and fixed time methods have been successfully applied to the determination of nortriptyline hydrochloride in commercial dosage form."( Kinetic modelling for the assay of nortriptyline hydrochloride using potassium permanganate as oxidant.
Khan, S; Rahman, N, 2015
)
0.65
" The KMnO4-Fe(II) process can be sequentially dosed at intake points in water sources to achieve moderate inactivation of algae cells and to enhance algae removal in DWTPs thereafter."( KMnO4-Fe(II) pretreatment to enhance Microcystis aeruginosa removal by aluminum coagulation: Does it work after long distance transportation?
Lan, H; Liu, H; Liu, R; Miao, S; Qi, J; Qu, J; Xu, Q, 2016
)
0.43
" Results show that NaOCl dosing was effective in reducing the viability of algae, but precipitated little Mn."( Pretreatment of algae-laden and manganese-containing waters by oxidation-assisted coagulation: Effects of oxidation on algal cell viability and manganese precipitation.
Hua, LC; Huang, C; Lin, JL; Wu, Y, 2016
)
0.43
" Comparison between the theoretical phenol removal rates deduced by the above two equations and the initial phenol concentration as well as the CRP dosage with the experimental data indicates that the differences between them were less than 20%."( Characteristics and kinetics simulation of controlled-release KMnO4 for phenol remediation.
Dong, S; Huo, M; Xiong, H; Zhou, D; Zou, D,
)
0.13
" However, over dosed oxidants can result in more serious water quality risks due to significant algae cell lysis and undesirable intracellular organic matter release."( Pre-oxidation enhanced cyanobacteria removal in drinking water treatment: A review.
Hu, C; Liu, R; Ma, B; Miao, S; Qi, J; Qu, J, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,479)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990650 (43.95)18.7374
1990's197 (13.32)18.2507
2000's339 (22.92)29.6817
2010's244 (16.50)24.3611
2020's49 (3.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 91.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index91.05 (24.57)
Research Supply Index7.38 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index241.64 (26.88)
Search Engine Supply Index2.90 (0.95)

This Compound (91.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials13 (0.81%)5.53%
Reviews31 (1.94%)6.00%
Case Studies83 (5.20%)4.05%
Observational0 (0.00%)0.25%
Other1,469 (92.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]